Vetplasma Pet Infusion

Vetplasma Pet Infusion is given only as an intravenous infusion under the supervision of a veterinarian. The amount and rate of administration depend on the animal’s condition, the degree of blood or fluid loss, and the response to treatment. The infusion is usually started slowly so the animal can be closely observed for any reaction, especially during the early phase of administration.

Most common side effects of this Vetplasma Pet Infusion are itching and hemodilution (dilution of blood). Careful monitoring during infusion helps detect side effects early and allows prompt management. Most reactions improve once treatment is discontinued and supportive care is provided.

Vetplasma Pet Infusion should not be used in animals with known hypersensitivity to hydroxyethyl starch or in conditions where fluid overload is already present, such as pulmonary edema or congestive heart failure. It is also contraindicated in animals with severe kidney failure associated with reduced or absent urine production, severe electrolyte imbalances, or intracranial bleeding. Caution is advised in animals with kidney disease, liver disease, or bleeding disorders, as the medicine may affect coagulation and fluid balance.

• Treatment and prophylaxis of Hypovolemia

• Ensure your pet receives treatment in a veterinary clinic where proper monitoring equipment is available, as this infusion requires close observation during administration.
• Inform the veterinarian about your pet’s full medical history, especially kidney disease, heart problems, bleeding disorders, or any previous reactions to intravenous fluids, before starting the treatment.
• Allow your pet to rest after the infusion and avoid excessive physical activity until the veterinarian confirms that circulation and hydration status have stabilised.
• Provide access to clean drinking water unless your veterinarian advises otherwise, as maintaining appropriate hydration supports recovery alongside medical treatment.
• Follow all follow-up visit recommendations, since reassessment may be needed to monitor fluid balance, kidney function, and overall recovery from the underlying condition that caused hypovolemia.